News | November 17, 2010

Grant Renewed for Innovative Molecular Imaging Center

November 17, 2010 — A five-year, $10 million grant supporting a leading-edge molecular imaging center at UCLA has been renewed by the National Cancer Institute (NCI) for a third cycle, bringing the total support for the center to $30 million.

The grant funds the UCLA Center for In Vivo Imaging in Cancer Biology, one of the NCI’s eight specialized In Vivo Cellular and Molecular Imaging Centers (ICMICs). UCLA’s ICMIC brings together the expertise and experience of innovative scientists from UCLA’s Jonsson Comprehensive Cancer Center, the Molecular and Medical Pharmacology Department, the Crump Institute for Molecular Imaging and the Institute for Molecular Medicine.

The UCLA ICMIC has developed and applied both instruments and technologies that allow researchers to repeatedly, noninvasively and quantitatively observe such functions as immune responses in real time, as the body detects and then attempts to ward off cancer, has allowed oncologists to more quickly determine whether alternative therapies are working and has developed imaging techniques to stratify cancer patients for initial therapies.

“Understanding cancer at its molecular and cellular levels, and being able to image these aberrant processes in living individuals plays a key role in improving the diagnosis, monitoring and treatment of cancer. In addition, monitoring the distribution and fate of therapeutic molecules provides an enormous advantage in manipulating and evaluating their efficacy," said Harvey Herschman, principal investigator of the UCLA ICMIC. “The new technologies that are emerging from our center are providing valuable new tools for cancer researchers, allowing them to investigate questions in ways not previously feasible.”

The first UCLA ICMIC grant, awarded in 2001, allowed scientists to extend the development and use of noninvasive molecular imaging technologies, such as positron emission tomography (PET), first pioneered at UCLA. Those efforts resulted in making these new technologies part of the regular “toolbox” used by molecular and cell biologists at UCLA who were studying cancer in animal models.

The second ICMIC grant, awarded in 2005, allowed the scientific advances made in the first five years to be translated into the clinic to improve the diagnosis and staging of cancer.

Projects funded by the ICMIC grant have included optimizing PET imaging technologies to rapidly monitor metabolic responses of brain and lung tumors to experimental therapies. Researchers have been able to identify those tumors sensitive to a drug by showing a metabolic response and distinguishing them from nonresponders. Metabolic measures of response are detectable much earlier than the structural changes in tumors usually measured in current clinical procedures, so doctors can tell more quickly if a drug is working and patients can be spared treatments with toxic side effects.

Another translational project involved the use of reporter genes to mark modified immune cells used to stimulate the body’s own response to melanomas. Researchers are able trace injected immune cells carrying the reporter genes, using imaging, and determine their location, their ability to target tumor tissue, their longevity in patients and their biological activity.

Herschman said this round of funding will allow UCLA researchers to develop new imaging instrumentation, technology and potential therapeutic and imaging agents, to test these advances in preclinical models and to initiate clinical trials in cancer patients.

Judith C. Gasson, director of the Jonsson Cancer Center, said discoveries made in UCLA’s ICMIC hold tremendous potential for cancer research and patient care.

“These discoveries will hasten development of safe, effective treatments for patients by allowing researchers to more rapidly and thoroughly evaluate the benefits and limitations of experimental therapies,” she said.

For more information: www.cancer.ucla.edu

Related Content

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model.

A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D.

Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis
Three-dimensional (3-D) printing and...
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

Sponsored Content | Case Study | Ultrasound Imaging | July 01, 2019
“With our present technology, we often struggle with large patients,” said Richard G.
David Anderson at SIIM

David Anderson presents information about the development of artificial Intelligence (AI) at SIIM 2019 as his father, Charles, looks on from a front row seat. The father-son team presented information at the SIIM annual meeting about their use of relatively shallow Deep Learning networks to analyze chest radiographs with AI.

Feature | Information Technology | July 01, 2019 | By Greg Freiherr
Two simple neural networks are better than one complex one, according to a father-son team of entrepreneurs.
Philips Pinnacle

Image courtesy of Philips Healthcare

Feature | Treatment Planning | July 01, 2019 | By Jeff Zagoudis

Image courtesy of Philips Healthcare

Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging.
GE OEC Elite MiniView

Image courtesy of GE Healthcare

Feature | Mobile C-Arms | July 01, 2019 | By Paramjit “Romi” Chopra, M.D.
A mobile C-arm is a medical imaging